Form 4: Robert F. Williamson III Acquires 23,000 Stock Options in Perspective Therapeutics
SEC Filing Form 4
Director Robert F. Williamson III acquired 23,000 stock options in Perspective Therapeutics, Inc. on June 20, 2024.
Summary
- Robert F. Williamson III, a director of Perspective Therapeutics, Inc., filed a Form 4 on June 24, 2024.
- The form reports a transaction that occurred on June 20, 2024, where Williamson acquired 23,000 stock options.
- The exercise price of these options is $10.65.
- The options vest fully on the first anniversary of the grant date (June 20, 2024) and expire on June 20, 2034.
- Following the transaction, Williamson directly owns 23,000 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock option grants, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, trade in their company's stock. These filings provide transparency to the market regarding insider activity.
Stakeholder Impact
- The acquisition of stock options by a director can be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 06/20/2024 | Date of earliest transaction: acquisition of stock options. |
| 06/20/2024 | Grant Date: Options vest fully one year after this date. |
| 06/20/2034 | Expiration Date: Options expire on this date. |
| 06/24/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.